TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites and peripheral edema. These complications increase hospitalization for cardiac failure and mortality. 

The TRILUMINATE Pivotal included 572 patients with moderate to severe TR randomized to edge-to-edge combined with optimal medical treatment (T TEER, 285 patients) or optimal medical treatment alone (OMT, the remaining patients).

Kidney function was assessed with eGFR and liver function with MELD-XI (Model for End-Stage Liver Disease excluding INR). Primary end point was death or hospitalization at 12 months.

Patient Baseline Characteristics

Both groups had similar baseline characteristics. Mean age was 78, 59% were women, over half were in functional class III-IV. Other relevant findings were:

  • Atrial fibrillation: 88%
  • Hypertension: 80%
  • Prior mitral or aortic intervention: 37%
  • Kidney function deterioration: 33%
  • Pacemaker presence: 16%
  • Liver disease: 7%
  • Infarction: 4%
  • Stroke: 8%

50% presented torrential TR, 21% massive, 28% severe and the rest, moderate. Mean eGFR was 53.9 ± 14.0 mL/min/1.73 m², and mean MELD-XI score was 10.2 ± 3.5.

Read also: FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR.

Results: edge-to-edge (T TEER) in severe tricuspid regurgitation

After T TEER, there was significant reduction of TR in 92% of patients, sustained over a year. 

The MELD-XI improved significantly among TEER patients (-0.11 ± 0.13 vs. 0.41 ± 0.13; p=0.0043), while there were no significant differences in eGFR (-0.10 ± 0.79 vs. -2.22 ± 0.82 mL/min/1.73 m²; p=0.063).

However, in patients with successful TEER (moderate or mild TR), both parameters showed improvement. 

  • eGFR: +3.55 ± 1.04 mL/min/1.73 m² (vs. 0.07 ± 1.10 mL/min/1.73 m² in the control group; p=0.022).
  • MELD-XI: -0.52 ± 0.18 points (vs. 0.34 ± 0.18 increase in the control group; p=0.0007).

    The clinical analysis did not show differences in mortality or hospitalization between the groups. However, patients with moderate to severe kidney function deterioration at baseline showed higher rates of hospitalization for cardiac failure (0.34 events/year; p<0.001), regardless treatment type.

    Read also: Secondary Access in TAVI: Is Transradial Approach our Best Bet?

    In this subgroup, the primary end point resulted lower among T TEER patients (28.9% vs. 36.2%; p=0.40), though with no statistical significance. 

    Conclusion: Effects of severe TR and TRILUMINATE Pivotal outcomes on renal and liver failure 

    Severe kidney and liver function deterioration are associated to higher hospitalization and mortality rates in patients with severe TR. At 12 months, there were no statistically significant differences in eGFR and MELD-XI between the groups. However, in patients with successful TEER, there was mild improvement in both parameters. Further studies are required to assess the impact of these changes in the terminal kidney and liver failure, an also in hospitalization and mortality reduction. 

    Original Title: Clinical Outcomes of Transcatheter Edge-to-Edge Tricuspid Valve Repair and Organ Function in Severe Tricuspid Regurgitation: TRILUMINATE Trial.

    Reference: Ulrich P. Jorde et al. Journal of the American College of Cardiology, Volumen 84, 2446–2456, 2024.


    Subscribe to our weekly newsletter

    Get the latest scientific articles on interventional cardiology

     

    Dr. Carlos Fava
    Dr. Carlos Fava
    Member of the Editorial Board of solaci.org

    More articles by this author

    TAVR and Surgical Bailout: Temporal Trends and Clinical Implications

    The evolution of transcatheter aortic valve replacement (TAVR), both regarding its planning and execution, has resulted in minimally invasive interventions with high safety levels....

    Edge-to-Edge Repair in Atrial Secondary Tricuspid Regurgitation

    Tricuspid regurgitation (TR) has been associated with higher morbimortality and a negative impact on quality of life.  In most cases, its main cause is a...

    Percutaneous Treatment of Tricuspid Regurgitation with K-CLIP

    Roughly 4% of the adult population presents tricuspid regurgitation (TR), a condition that might progress to severe or worse end-organ function, associated to hospitalizations...

    PULSE Registry Subanalysis: Radial vs. Femoral Secondary Access

    In view of its lower complications rate, the transfemoral approach is the most used in transcatheter aortic valve replacement (TAVR), vs. alternative access sites....

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Related Articles

    SOLACI Sessionsspot_img

    Recent Articles

    RODIN-CUT: Successive Cutting Balloon Technique in Calcified Lesions

    Moderate or severe coronary calcification can be a marker of poor prognosis in coronary artery disease, as it significantly increases the risk of failure...

    Acute Coronary Syndrome with Multivessel Disease: Best Revascularization Strategy

    The gold standard treatment for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) is primary angioplasty (PCI). However, 40 to 70% of ACS...

    Improved Ejection Fraction in Chronic Total Occlusion?

    Chronic total occlusions (CTO) represent a significant challenge in the current clinical practice, seeing as CTO percutaneous coronary intervention (PCI) is complex and involves...